ONXX and Bayer Wonder how can a big phama modify its biotech partner product and get 100% of the next generation drug's sale. If there is a legal leeway to do that, all small bioteches shall be very careful. What probability can onxx win over it?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.